Efficacy and prognosis of HER2-Low and HER2-Zero in triple-negative breast cancer after neoadjuvant chemotherapy

July 23, 2024 Health Trends, Health Trends - Australia

Clinicopathologic characteristics analysis between HER2-Low and HER2-Zero patients

A total of 638 TNBC patients were analyzed in the present study. Baseline demographics and clinical–pathological characteristics stratified by HER2 status were summarized in Table1. In the entire cohort, 342…

Source link

A note to our visitors

This website has updated its privacy policy in compliance with changes to European Union data protection law, for all members globally. We’ve also updated our Privacy Policy to give you more information about your rights and responsibilities with respect to your privacy and personal information. Please read this to review the updates about which cookies we use and what information we collect on our site. By continuing to use this site, you are agreeing to our updated privacy policy.

Efficacy and prognosis of HER2-Low and HER2-Zero in triple-negative breast cancer after neoadjuvant chemotherapy

Clinicopathologic characteristics analysis between HER2-Low and HER2-Zero patients

Recent Posts

Recent Comments